Oncologist
Journal Abbreviation: ONCOLOGIST
ISSN: 1083-7159
eISSN: 1549-490X
Publisher: Oxford University Press
Publications (10)
Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2- Advanced Breast Cancer: Findings From a Multicountry Survey (2023)
Cardoso F, Rihani J, Harmer V, Harbeck N, Casas A, Rugo HS, Fasching P, et al.
Journal article
Evaluating the Effectiveness of Mobile Health in Breast Cancer Care: A Systematic Review (2023)
Flaucher M, Zakreuskaya A, Nissen M, Mocker A, Fasching P, Beckmann M, Eskofier B, Leutheuser H
Journal article, Review article
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms (2022)
Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree JS, Hann CL, et al.
Journal article, Review article
CIC mutation as a molecular mechanism of acquired resistance to combined braf-mek inhibition in extramedullary multiple myeloma with central nervous system involvement (2020)
Da Via MC, Solimando AG, Garitano-Trojaola A, Barrio S, Munawar U, Strifler S, Haertle L, et al.
Journal article
Implementation of Best Practice Recommendations for Palliative Care in German Comprehensive Cancer Centers (2019)
Gahr S, Lödel S, Berenot J, Thomas M, Ostgathe C
Journal article
Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors (2019)
Pavel ME, Phan AT, Wolin EM, Mirakhur B, Liyanage N, Pitman Lowenthal S, Fisher GA, Vinik AI
Journal article
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome. (2019)
Anthony LB, Kulke MH, Caplin ME, Bergsland E, Oberg K, Pavel M, Hoersch D, et al.
Journal article
Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2) (2019)
Merten R, Ott O, Haderlein M, Bertz S, Hartmann A, Wullich B, Keck B, et al.
Journal article
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study (2019)
Lamarca A, Crona J, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, et al.
Journal article, Review article
Integrating Palliative Care Into Comprehensive Cancer Centers: Consensus-Based Development of Best Practice Recommendations (2016)
Berendt J, Stiel S, Simon ST, Schmitz A, Oorschot B, Stachura P, Ostgathe C
Journal article